Acurx Pharmaceuticals, Inc.
ACXP· Nasdaq
ACXPAcurx Pharmaceuticals, Inc.
Filed May 12, 2025 · 10-Q · 42 days after period end · 0001558370-25-007371
| Metric | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|
| Net Income | -$2.15M | -$4.38M | -$2.90M | -$2.67M |
| EPS Diluted | -$2.15 | -$0.28 | -$0.25 | -$0.26 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Acurx Pharmaceuticals, Inc. · CIK 1736243 · Engraved from SEC EDGAR
ended Mar 31, 2025 · filed May 12, 2025 · 42 d after period end
